rs1062923

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015721.3(GEMIN4):​c.2216T>C​(p.Ile739Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.155 in 1,612,720 control chromosomes in the GnomAD database, including 21,350 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1402 hom., cov: 32)
Exomes 𝑓: 0.16 ( 19948 hom. )

Consequence

GEMIN4
NM_015721.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.09

Publications

50 publications found
Variant links:
Genes affected
GEMIN4 (HGNC:15717): (gem nuclear organelle associated protein 4) The product of this gene is part of a large complex localized to the cytoplasm, nucleoli, and to discrete nuclear bodies called Gemini bodies (gems). The complex functions in spliceosomal snRNP assembly in the cytoplasm, and regenerates spliceosomes required for pre-mRNA splicing in the nucleus. The encoded protein directly interacts with a DEAD box protein and several spliceosome core proteins. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
GEMIN4 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0043025613).
BP6
Variant 17-745827-A-G is Benign according to our data. Variant chr17-745827-A-G is described in ClinVar as Benign. ClinVar VariationId is 1185307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.166 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015721.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GEMIN4
NM_015721.3
MANE Select
c.2216T>Cp.Ile739Thr
missense
Exon 2 of 2NP_056536.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GEMIN4
ENST00000319004.6
TSL:1 MANE Select
c.2216T>Cp.Ile739Thr
missense
Exon 2 of 2ENSP00000321706.5
GEMIN4
ENST00000576778.1
TSL:6
c.2183T>Cp.Ile728Thr
missense
Exon 1 of 1ENSP00000459565.1

Frequencies

GnomAD3 genomes
AF:
0.119
AC:
18088
AN:
152052
Hom.:
1401
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0313
Gnomad AMI
AF:
0.171
Gnomad AMR
AF:
0.111
Gnomad ASJ
AF:
0.194
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.111
Gnomad FIN
AF:
0.184
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.169
Gnomad OTH
AF:
0.124
GnomAD2 exomes
AF:
0.130
AC:
32146
AN:
247698
AF XY:
0.135
show subpopulations
Gnomad AFR exome
AF:
0.0280
Gnomad AMR exome
AF:
0.0692
Gnomad ASJ exome
AF:
0.182
Gnomad EAS exome
AF:
0.000613
Gnomad FIN exome
AF:
0.190
Gnomad NFE exome
AF:
0.167
Gnomad OTH exome
AF:
0.145
GnomAD4 exome
AF:
0.159
AC:
231980
AN:
1460550
Hom.:
19948
Cov.:
59
AF XY:
0.159
AC XY:
115203
AN XY:
726520
show subpopulations
African (AFR)
AF:
0.0272
AC:
909
AN:
33464
American (AMR)
AF:
0.0714
AC:
3186
AN:
44650
Ashkenazi Jewish (ASJ)
AF:
0.192
AC:
5007
AN:
26116
East Asian (EAS)
AF:
0.000731
AC:
29
AN:
39694
South Asian (SAS)
AF:
0.124
AC:
10681
AN:
86186
European-Finnish (FIN)
AF:
0.195
AC:
10282
AN:
52722
Middle Eastern (MID)
AF:
0.190
AC:
1092
AN:
5760
European-Non Finnish (NFE)
AF:
0.172
AC:
191629
AN:
1111614
Other (OTH)
AF:
0.152
AC:
9165
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
11436
22872
34307
45743
57179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6620
13240
19860
26480
33100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.119
AC:
18079
AN:
152170
Hom.:
1402
Cov.:
32
AF XY:
0.118
AC XY:
8801
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.0313
AC:
1299
AN:
41568
American (AMR)
AF:
0.111
AC:
1697
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.194
AC:
673
AN:
3470
East Asian (EAS)
AF:
0.00136
AC:
7
AN:
5162
South Asian (SAS)
AF:
0.111
AC:
535
AN:
4828
European-Finnish (FIN)
AF:
0.184
AC:
1941
AN:
10572
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.169
AC:
11458
AN:
67958
Other (OTH)
AF:
0.122
AC:
258
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
797
1594
2392
3189
3986
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
206
412
618
824
1030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.148
Hom.:
6978
Bravo
AF:
0.109
TwinsUK
AF:
0.167
AC:
619
ALSPAC
AF:
0.165
AC:
636
ESP6500AA
AF:
0.0342
AC:
134
ESP6500EA
AF:
0.169
AC:
1404
ExAC
AF:
0.127
AC:
15391
Asia WGS
AF:
0.0490
AC:
170
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GEMIN4-related disorder Benign:1
Oct 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.80
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
4.3
DANN
Benign
0.75
DEOGEN2
Benign
0.029
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.31
N
LIST_S2
Benign
0.63
T
MetaRNN
Benign
0.0043
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.49
N
PhyloP100
1.1
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-2.1
N
REVEL
Benign
0.063
Sift
Benign
0.14
T
Sift4G
Benign
0.23
T
Polyphen
0.0010
B
Vest4
0.035
MPC
0.17
ClinPred
0.014
T
GERP RS
-2.2
Varity_R
0.086
gMVP
0.20
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1062923; hg19: chr17-649067; COSMIC: COSV56746058; COSMIC: COSV56746058; API